Navigation Links
Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs
Date:3/4/2008

New Study Shows Benefits in Patients Diagnosed with Staphylococcal, HIV, Tuberculosis and Other Infectious Diseases

WASHINGTON, March 4 /PRNewswire-USNewswire/ -- Testing hospitalized patients for drug-resistant infections can reduce mortality, decrease length of stay and reduce cost of care, according to a new report released today by AdvaMed, the Advanced Medical Technology Association. The report describes how diagnostic testing can identify drug resistance, allowing physicians to adjust medications or take other steps to more effectively treat patients with staphylococcal (staph) and other infectious diseases such as HIV and tuberculosis.

"These findings show such large benefits in cost savings and health outcomes that antimicrobial susceptibility tests should be performed on all patients with these diagnoses," said report author Frank Lichtenberg, Ph.D., Courtney C. Brown Professor of Business, Columbia University Graduate School of Business. "Widespread testing for drug-resistant infections is a small investment that yields high returns for patients, for hospitals and for the health care system overall."

The potential impact of testing for drug-resistant infections is significant as the number of U.S. hospital discharges that include a diagnosis of infection with a drug-resistant microorganism has increased more than 100-fold from 1993-2005 -- from 3,000 to 394,000.

"Dr. Lichtenberg's report provides further evidence of the incredible benefits to patients and the value provided to the health care system from diagnostic testing," said Stephen J. Ubl, president and CEO of AdvaMed. "These technologies are the foundation of the personalized medicine revolution that match the best treatment option with each individual patient. State-of-the-art diagnostic testing will help dramatically lower health care costs by eliminating unnecessary or ineffective treatments, but more importantly providing patients with the right treatment sooner."

The report indicates that patients tested for antimicrobial susceptibility had significantly lower mortality rates, lengths of stay, and overall treatment costs than patients who were not tested.

Key findings include:

-- Among patients with a secondary staph infection diagnosis, those tested for antimicrobial susceptibility had 52 percent lower probability of death before discharge, 17 percent lower mean length of stay (-1.8 days), and 22 percent lower cost than those who did not. Antimicrobial testing in this group was associated with $6,978 lower cost per discharge. The potential aggregate cost reduction from antimicrobial susceptibility testing of all patients hospitalized with this diagnosis in 2005 was $8.3 billion.

-- Among patients with any infectious and parasitic disease diagnosis, those tested for antimicrobial susceptibility had 30 percent lower probability of death before discharge, 26 percent lower mean length of stay (-1.8 days), and 36 percent lower cost than those who did not. Antimicrobial susceptibility testing in this group is associated with $7,524 lower cost per discharge.

To access a copy of the full report, please visit the News Room section of AdvaMed's Web site at http://www.advamed.org.

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit http://www.advamed.org.


'/>"/>
SOURCE AdvaMed
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
2. Risk of surgery for lung cancer lower at teaching hospitals
3. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
4. Anthem Blue Cross and Blue Shields Promoting Healthcare Quality Program Improves Quality and Patient Safety in 19 Colorado Hospitals
5. Jeffrey Modell Foundation and Talecris Biotherapeutics Expand Diagnostic Services for Primary Immunodeficiencies at Lucile Packard Childrens Hospital at Stanford
6. APIC Issues Recommendations on How to Have a Healthy Hospital Stay
7. AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals
8. AT&T Provides In-Building Wireless Services to Thomas Jefferson University and Hospital
9. St. Louis University Hospital Purchases Second CyberKnife(R) System
10. Black VLBW babies in NYC more likely to be born in hospitals with high neonatal death rates
11. UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... RU (PRWEB) , ... June 26, 2017 , ... ... released a whitepaper that pledges to solve many catastrophic issues within funding campaigns. ... 2017. , The typical notion of crowdfunding - the raising of funds through the ...
(Date:6/25/2017)... ... ... FCPX LUT Vintage Volume 2 for Final Cut Pro X allows users ... contains 60 different color-grade presets, giving editors multiple options for adding different color options. ... subjects, plus much more. FCPX LUT Vintage Volume 2 is designed for any skill-set ...
(Date:6/25/2017)... ... ... Republicans in the United States Senate on Thursday released their version of ... differs significantly from the American Health Care Act, which the House passed in May, ... will have to take up the Senate version as-is, if it passes. , The ...
(Date:6/25/2017)... ... , ... CareSet Labs released the Root NPI Graph today at the 2017 ... improved version of the Doctor Referral teaming dataset commonly available from Medicare. , Originally ... the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released by ...
(Date:6/25/2017)... ... 2017 , ... June is Men’s Health Month and the focus is on prostate ... in the U.S. and the third most common cause of cancer related death today; lung ... seven will be diagnosed with prostate cancer during his lifetime. Those at highest risk ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology: